Plus Therapeutics Files 8-K with Corporate Updates

Ticker: PSTV · Form: 8-K · Filed: May 2, 2025 · CIK: 1095981

Plus Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyPlus Therapeutics, Inc. (PSTV)
Form Type8-K
Filed DateMay 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, filing, financials

TL;DR

PLUS THERAPEUTICS filed an 8-K covering bylaws, shareholder votes, and financials. Major corporate housekeeping.

AI Summary

On May 2, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report detailing several corporate events. These include amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and the filing of financial statements and exhibits. The company, formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC, is incorporated in Delaware and has its fiscal year end on December 31.

Why It Matters

This 8-K filing indicates significant corporate actions and disclosures by Plus Therapeutics, Inc., which could impact investors' understanding of the company's governance and financial status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting corporate events and does not indicate any immediate financial distress or significant negative developments.

Key Numbers

  • 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

  • PLUS THERAPEUTICS, INC. (company) — Registrant
  • CYTORI THERAPEUTICS, INC. (company) — Former Company Name
  • MACROPORE INC (company) — Former Company Name
  • Delaware (jurisdiction) — State of Incorporation

FAQ

What specific amendments were made to the articles of incorporation or bylaws?

The filing indicates amendments were made but does not specify the exact nature of these amendments in the provided text.

What matters were submitted to a vote of security holders?

The filing states that matters were submitted to a vote, but the specific proposals are not detailed in this excerpt.

What financial statements and exhibits are included in this filing?

The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in this summary.

When was the company formerly known as CYTORI THERAPEUTICS, INC.?

The date of the name change from CYTORI THERAPEUTICS, INC. to PLUS THERAPEUTICS, INC. was July 12, 2005.

What is the business address of PLUS THERAPEUTICS, INC.?

The business address is 4200 MARATHON BLVD., SUITE 200, AUSTIN, TX 78756.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 2, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.